{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T22:07:47Z","timestamp":1780956467284,"version":"3.54.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T00:00:00Z","timestamp":1565654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T00:00:00Z","timestamp":1565654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"This work was supported by the Recursos Fiscales para Investigaci&amp;#x00F3;n Program from the Instituto Nacional de Pediatr&amp;#x00ED;a"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>Giardia lamblia<\/jats:italic> is the causal agent of giardiasis, one of the most prevalent parasitosis in the world. Even though effective pharmacotherapies against this parasite are available, the disadvantages associated with its use call for the development of new antigiardial compounds. Based on the <jats:italic>Giardia<\/jats:italic> dependence on glycolysis as a main energy source, glycolytic enzymes appear to be attractive targets with antiparasitic potential. Among these, fructose 1,6-biphosphate aldolase (GlFBPA) has been highlighted as a promising target for drug design. Current efforts are based on the design of competitive inhibitors of GlFBPA; however, in the kinetic context of metabolic pathways, competitive inhibitors seem to have low potential as therapeutic agents. In this work, we performed an experimental and <jats:italic>in silico<\/jats:italic> structure-based approach to propose a non-catalytic binding site which could be used as a hot spot for antigardial drug design. The druggability of the selected binding site was experimentally tested; the alteration of the selected region by site directed mutagenesis disturbs the catalytic properties and the stability of the enzyme. A computational automated search of binding sites supported the potential of this region as functionally relevant. A preliminary docking study was performed, in order to explore the feasibility and type of molecules to be able to accommodate in the proposed binding region. Altogether, the results validate the proposed region as a specific molecular binding site with pharmacological potential.<\/jats:p>","DOI":"10.1038\/s41598-019-48192-3","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T10:02:28Z","timestamp":1565690548000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Structure-based identification of a potential non-catalytic binding site for rational drug design in the fructose 1,6-biphosphate aldolase from Giardia lamblia"],"prefix":"10.1038","volume":"9","author":[{"given":"Sara-Teresa","family":"M\u00e9ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Castillo-Villanueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Mart\u00ednez-Mayorga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horacio","family":"Reyes-Vivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7147-1879","authenticated-orcid":false,"given":"Jes\u00fas","family":"Oria-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,13]]},"reference":[{"key":"48192_CR1","unstructured":"Garc\u00eda-Torres, I. et al. Novel therapeutic approaches for protozoan parasitic diseases. In Current Topics of Drug Design in Parasitic and Bacterial Diseases (eds T\u00e9llez-Valencia, A. & Pedraza-Reyes, M.) 49\u201366 (Transworld Research Network, 2012)."},{"key":"48192_CR2","doi-asserted-by":"publisher","first-page":"i5369","DOI":"10.1136\/bmj.i5369","volume":"355","author":"C Minetti","year":"2016","unstructured":"Minetti, C., Chalmers, R. M., Beeching, N. J., Probert, C. & Lamden, K. Giardiasis. BMJ. 355, i5369, https:\/\/doi.org\/10.1136\/bmj.i5369 (2016).","journal-title":"BMJ."},{"key":"48192_CR3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.pt.2006.02.015","volume":"22","author":"L Savioli","year":"2006","unstructured":"Savioli, L., Smith, H. & Thompson, A. Giardia and Cryptosporidium join the \u2018Neglected Diseases Initiative\u2019. Trends Parasitol. 22, 203\u2013208, https:\/\/doi.org\/10.1016\/j.pt.2006.02.015 (2006).","journal-title":"Trends Parasitol."},{"key":"48192_CR4","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0889-8553(05)70260-0","volume":"25","author":"MJ Farthing","year":"1996","unstructured":"Farthing, M. J. Giardiasis. Gastroenterol Clin North Am. 25, 493\u2013515, https:\/\/doi.org\/10.1016\/S0889-8553(05)70260-0 (1996).","journal-title":"Gastroenterol Clin North Am."},{"key":"48192_CR5","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2147\/BTT.S3943","volume":"3","author":"HG Busatti","year":"2009","unstructured":"Busatti, H. G., Santos, J. F. & Gomes, M. A. The old and new therapeutic approaches to the treatment of giardiasis: where are we? Biologics. 3, 273\u2013287, https:\/\/doi.org\/10.2147\/BTT.S3943 (2009).","journal-title":"Biologics."},{"key":"48192_CR6","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1007\/s11908-014-0396-y","volume":"16","author":"RR Watkins","year":"2014","unstructured":"Watkins, R. R. & Eckmann, L. Treatment of giardiasis: current status and future directions. Curr Infect Dis Rep. 16, 396\u2013403, https:\/\/doi.org\/10.1007\/s11908-014-0396-y (2014).","journal-title":"Curr Infect Dis Rep."},{"key":"48192_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1128\/AAC.43.1.73","volume":"43","author":"JA Upcroft","year":"1999","unstructured":"Upcroft, J. A., Campbell, R. W., Benakli, K., Upcroft, P. & Vanelle, P. Efficacy of new 5-nitroimidazoles against metronidazole-susceptible and resistant Giardia, Trichomonas, and Entamoeba spp. Antimicrob Agents Chemother. 43, 73\u201376 (1999).","journal-title":"Antimicrob Agents Chemother."},{"key":"48192_CR8","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.pt.2003.09.003","volume":"19","author":"W Petri","year":"2003","unstructured":"Petri, W. Therapy of intestinal protozoa. Trends Parasitol. 19, 523\u2013526, https:\/\/doi.org\/10.1016\/j.pt.2003.09.003 (2003).","journal-title":"Trends Parasitol."},{"key":"48192_CR9","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2174\/187152610791591610","volume":"10","author":"M Lalle","year":"2010","unstructured":"Lalle, M. Giardiasis in the post genomic era: treatment, drug resistance and novel therapeutic perspectives. Infect Disord Drug Targets. 10, 283\u2013294, https:\/\/doi.org\/10.2174\/187152610791591610 (2010).","journal-title":"Infect Disord Drug Targets."},{"key":"48192_CR10","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2174\/187152610791591629","volume":"10","author":"HF Tian","year":"2010","unstructured":"Tian, H. F., Chen, B. & Wen, J. F. Giardiasis, drug resistance, and new target discovery. Infect Disord Drug Targets. 10, 295\u2013302, https:\/\/doi.org\/10.2174\/187152610791591629 (2010).","journal-title":"Infect Disord Drug Targets."},{"key":"48192_CR11","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s40475-015-0051-1","volume":"2","author":"D Leitsch","year":"2015","unstructured":"Leitsch, D. Drug Resistance in the Microaerophilic Parasite Giardia lamblia. Curr Trop Med Rep. 2, 128\u2013135, https:\/\/doi.org\/10.1007\/s40475-015-0051-1 (2015).","journal-title":"Curr Trop Med Rep."},{"key":"48192_CR12","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.biotechadv.2015.04.009","volume":"33","author":"BR Ansell","year":"2015","unstructured":"Ansell, B. R. et al. Drug resistance in Giardia duodenalis. Biotechnol Adv. 33, 888\u2013901, https:\/\/doi.org\/10.1016\/j.biotechadv.2015.04.009 (2015).","journal-title":"Biotechnol Adv."},{"key":"48192_CR13","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/QCO.0b013e32834ad401","volume":"24","author":"N Tejman-Yarden","year":"2011","unstructured":"Tejman-Yarden, N. & Eckmann, L. New approaches to the treatment of giardiasis. Curr Opin Infect Dis. 24, 451\u2013456, https:\/\/doi.org\/10.1097\/QCO.0b013e32834ad401 (2011).","journal-title":"Curr Opin Infect Dis."},{"key":"48192_CR14","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/prot.20097","volume":"55","author":"G L\u00f3pez-Vel\u00e1zquez","year":"2004","unstructured":"L\u00f3pez-Vel\u00e1zquez, G. et al. An unusual triosephosphate isomerase from the early divergent eukaryote Giardia lamblia. Proteins. 55, 824\u2013834, https:\/\/doi.org\/10.1002\/prot.20097 (2004).","journal-title":"Proteins."},{"key":"48192_CR15","doi-asserted-by":"publisher","first-page":"4859","DOI":"10.1074\/jbc.M609534200","volume":"282","author":"A Galkin","year":"2007","unstructured":"Galkin, A. et al. Characterization, kinetics, and crystal structures of fructose-1,6-bisphosphate aldolase from the human parasite, Giardia lamblia. J Biol Chem. 282, 4859\u20134867, https:\/\/doi.org\/10.1074\/jbc.M609534200 (2007).","journal-title":"J Biol Chem."},{"key":"48192_CR16","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1146\/annurev.mi.42.100188.002341","volume":"42","author":"M M\u00fcller","year":"1988","unstructured":"M\u00fcller, M. Energy metabolism of protozoa without mitochondria. Annu Rev Microbiol. 42, 465\u2013488, https:\/\/doi.org\/10.1146\/annurev.mi.42.100188.002341 (1988).","journal-title":"Annu Rev Microbiol."},{"key":"48192_CR17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0378-1119(98)00499-5","volume":"222","author":"K Henze","year":"1998","unstructured":"Henze, K., Morrison, H. G., Sogin, M. L. & M\u00fcller, M. Sequence and phylogenetic position of a class II aldolase gene in the amitochondriate protist, Giardia lamblia. Gene. 222, 163\u2013168, https:\/\/doi.org\/10.1016\/S0378-1119(98)00499-5 (1998).","journal-title":"Gene."},{"key":"48192_CR18","first-page":"1248","volume":"23","author":"WJ Rutter","year":"1964","unstructured":"Rutter, W. J. Evolution of aldolase. Fed Proc. 23, 1248\u20131257 (1964).","journal-title":"Fed Proc."},{"key":"48192_CR19","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1021\/bi9001166","volume":"48","author":"A Galkin","year":"2009","unstructured":"Galkin, A. et al. Structural insights into the substrate binding and stereoselectivity of giardia fructose-1,6-bisphosphate aldolase. Biochemistry. 48, 3186\u20133196, https:\/\/doi.org\/10.1021\/bi9001166 (2009).","journal-title":"Biochemistry."},{"key":"48192_CR20","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.jinorgbio.2010.12.012","volume":"105","author":"Z Li","year":"2011","unstructured":"Li, Z. et al. Rational design, synthesis and evaluation of first generation inhibitors of the Giardia lamblia fructose-1,6-biphosphate aldolase. J Inorg Biochem. 105, 509\u2013517, https:\/\/doi.org\/10.1016\/j.jinorgbio.2010.12.012 (2011).","journal-title":"J Inorg Biochem."},{"key":"48192_CR21","unstructured":"Cornish-Bowden, A. & Eisenthal, R. Prospects for pharmacological manipulation of metabolism. In New beer in an old bottle (ed. Cornish-Bowden, A.) 215\u2013224 (Universitat de Valencia, 1997)."},{"key":"48192_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0014-5793(86)81424-7","volume":"203","author":"A Cornish-Bowden","year":"1986","unstructured":"Cornish-Bowden, A. Why is uncompetitive inhibition so rare? A possible explanation, with implications for the design of drugs and pesticides. FEBS Lett. 203, 3\u20136, https:\/\/doi.org\/10.1016\/0014-5793(86)81424-7 (1986).","journal-title":"FEBS Lett."},{"key":"48192_CR23","doi-asserted-by":"publisher","first-page":"5347","DOI":"10.1074\/jbc.271.10.5347","volume":"271","author":"AM Westley","year":"1996","unstructured":"Westley, A. M. & Westley, J. Enzyme inhibition in open systems. Superiority of uncompetitive agents. J Biol Chem. 271, 5347\u20135352, https:\/\/doi.org\/10.1074\/jbc.271.10.5347 (1996).","journal-title":"J Biol Chem."},{"key":"48192_CR24","doi-asserted-by":"publisher","first-page":"W20","DOI":"10.1093\/nar\/gkh435","volume":"32","author":"S McGinnis","year":"2004","unstructured":"McGinnis, S. & Madden, T. L. BLAST: at the core of a powerful and diverse set of sequence analysis tools. Nucleic Acids Res. 32, W20\u201325, https:\/\/doi.org\/10.1093\/nar\/gkh435 (2004).","journal-title":"Nucleic Acids Res."},{"key":"48192_CR25","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1093\/nar\/gkv1189","volume":"44","author":"NA O\u2019Leary","year":"2016","unstructured":"O\u2019Leary, N. A. et al. Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation. Nucleic Acids Res. 44, 733\u2013745, https:\/\/doi.org\/10.1093\/nar\/gkv1189 (2016).","journal-title":"Nucleic Acids Res."},{"key":"48192_CR26","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1093\/bioinformatics\/btm404","volume":"23","author":"MA Larkin","year":"2007","unstructured":"Larkin, M. A. et al. Clustal W and Clustal X version 2.0. Bioinformatics. 23, 2947\u20132948, https:\/\/doi.org\/10.1093\/bioinformatics\/btm404 (2007).","journal-title":"Bioinformatics."},{"key":"48192_CR27","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1093\/protein\/7.11.1323","volume":"7","author":"SA Benner","year":"1994","unstructured":"Benner, S. A., Cohen, M. A. & Gonnet, G. H. Amino acid substitution during functionally constrained divergent evolution of protein sequences. Protein Eng. 7, 1323\u20131332, https:\/\/doi.org\/10.1093\/protein\/7.11.1323 (1994).","journal-title":"Protein Eng."},{"key":"48192_CR28","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W","volume":"19","author":"R Fraczkiewicz","year":"1998","unstructured":"Fraczkiewicz, R. & Braun, W. Exact and efficient analytical calculation of the accessible surface areas and their gradients for macromolecules. J. Comput. Chem. 19, 319\u2013333, https:\/\/doi.org\/10.1002\/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W (1998).","journal-title":"J. Comput. Chem."},{"key":"48192_CR29","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1101\/gr.849004","volume":"14","author":"GE Crooks","year":"2004","unstructured":"Crooks, G. E., Hon, G., Chandonia, J. M. & Brenner, S. E. WebLogo: a sequence logo generator. Genome Res. 14, 1188\u20131190, https:\/\/doi.org\/10.1101\/gr.849004 (2004).","journal-title":"Genome Res."},{"key":"48192_CR30","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/0003-2697(87)90587-2","volume":"166","author":"H Sch\u00e4gger","year":"1987","unstructured":"Sch\u00e4gger, H. & von Jagow, G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem. 166, 368\u2013379, https:\/\/doi.org\/10.1016\/0003-2697(87)90587-2 (1987).","journal-title":"Anal Biochem."},{"key":"48192_CR31","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ijpddr.2017.11.003","volume":"7","author":"A Castillo-Villanueva","year":"2017","unstructured":"Castillo-Villanueva, A. et al. Disulfiram as a novel inactivator of Giardia lamblia triosephosphate isomerase with antigiardial potential. Int J Parasitol Drugs Drug Resist. 7, 425\u2013432, https:\/\/doi.org\/10.1016\/j.ijpddr.2017.11.003 (2017).","journal-title":"Int J Parasitol Drugs Drug Resist."},{"key":"48192_CR32","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.molbiopara.2007.10.013","volume":"157","author":"S Enriquez-Flores","year":"2008","unstructured":"Enriquez-Flores, S. et al. Species-specific inhibition of Giardia lamblia triosephosphate isomerase by localized perturbation of the homodimer. Mol Biochem Parasitol. 157, 179\u2013186, https:\/\/doi.org\/10.1016\/j.molbiopara.2007.10.013 (2008).","journal-title":"Mol Biochem Parasitol."},{"key":"48192_CR33","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S1093-3263(98)00002-3","volume":"15","author":"M Hendlich","year":"1997","unstructured":"Hendlich, M., Rippmann, F. & Barnickel, G. LIGSITE: automatic and efficient detection of potential small molecule-binding sites in proteins. J Mol Graph Model. 15, 359\u2013363, https:\/\/doi.org\/10.1016\/S1093-3263(98)00002-3 (1997).","journal-title":"J Mol Graph Model."},{"key":"48192_CR34","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/0263-7855(93)85003-9","volume":"11","author":"CA Del Carpio","year":"1993","unstructured":"Del Carpio, C. A., Takahashi, Y. & Sasaki, S. A new approach to the automatic identification of candidates for ligand receptor sites in proteins: (I). Search for pocket regions. J Mol Graph. 11, 23\u201329, https:\/\/doi.org\/10.1016\/0263-7855(93)85003-9 (1993).","journal-title":"J Mol Graph."},{"key":"48192_CR35","unstructured":"Edelsbrunner, H. Weighted Alpha Shapes. Technical Report UIUCDCS-R-92-1760. Department of Computer Science. University of Illinois at Urbana-Champaign (1992)."},{"key":"48192_CR36","doi-asserted-by":"publisher","first-page":"e1004144","DOI":"10.1371\/journal.ppat.1004144","volume":"10","author":"S Puckett","year":"2014","unstructured":"Puckett, S. et al. Inactivation of fructose-1,6-bisphosphate aldolase prevents optimal co-catabolism of glycolytic and gluconeogenic carbon substrates in Mycobacterium tuberculosis. PLoS Pathog. 10, e1004144, https:\/\/doi.org\/10.1371\/journal.ppat.1004144 (2014).","journal-title":"PLoS Pathog."},{"key":"48192_CR37","doi-asserted-by":"publisher","first-page":"7453","DOI":"10.1021\/jf401939h","volume":"61","author":"D Li","year":"2013","unstructured":"Li, D. et al. Structure-based design and synthesis of novel dual-target inhibitors against cyanobacterial fructose-1,6-bisphosphate aldolase and fructose-1,6-bisphosphatase. J Agric Food Chem. 61, 7453\u20137461, https:\/\/doi.org\/10.1021\/jf401939h (2013).","journal-title":"J Agric Food Chem."},{"key":"48192_CR38","doi-asserted-by":"publisher","first-page":"7836","DOI":"10.1021\/jm1009814","volume":"53","author":"RM Daher","year":"2010","unstructured":"Daher, R. M. et al. Rational design, synthesis, and evaluation of new selective inhibitors of microbial class II (zinc dependent) fructose bis-phosphate aldolases. J Med Chem. 53, 7836\u20137842, https:\/\/doi.org\/10.1021\/jm1009814 (2010).","journal-title":"J Med Chem."},{"key":"48192_CR39","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jinorgbio.2012.02.032","volume":"112","author":"G Labb\u00e9","year":"2012","unstructured":"Labb\u00e9, G. et al. Development of metal-chelating inhibitors for the Class II fructose 1,6-bisphosphate (FBP) aldolase. J Inorg Biochem. 112, 49\u201358, https:\/\/doi.org\/10.1016\/j.jinorgbio.2012.02.032 (2012).","journal-title":"J Inorg Biochem."},{"key":"48192_CR40","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1021\/bi401022b","volume":"53","author":"GC Capodagli","year":"2014","unstructured":"Capodagli, G. C., Sedhom, W. G., Jackson, M., Ahrendt, K. A. & Pegan., S. D. A noncompetitive inhibitor for Mycobacterium tuberculosis\u2019s class IIa fructose 1,6-bisphosphate aldolase. Biochemistry. 53, 202\u2013213, https:\/\/doi.org\/10.1021\/bi401022b (2014).","journal-title":"Biochemistry."},{"key":"48192_CR41","doi-asserted-by":"publisher","first-page":"7604","DOI":"10.1021\/bi501141t","volume":"53","author":"GC Capodagli","year":"2014","unstructured":"Capodagli, G. C., Lee, S. A., Boehm, K. J., Brady, K. M. & Pegan, S. D. Structural and Functional Characterization of Methicillin-Resistant Staphylococcus aureus\u2019s Class IIb Fructose 1,6-Bisphosphate Aldolase. Biochemistry. 53, 7604\u20137614, https:\/\/doi.org\/10.1021\/bi501141t (2014).","journal-title":"Biochemistry."},{"key":"48192_CR42","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1021\/acs.jcim.5b00618","volume":"56","author":"X Han","year":"2016","unstructured":"Han, X. et al. A Rational Design, Synthesis, Biological Evaluation and Structure\u2013Activity Relationship Study of Novel Inhibitors against Cyanobacterial Fructose-1,6-bisphosphate Aldolase. J Chem Inf Model. 56, 73\u201381, https:\/\/doi.org\/10.1021\/acs.jcim.5b00618 (2016).","journal-title":"J Chem Inf Model."},{"key":"48192_CR43","doi-asserted-by":"publisher","first-page":"667","DOI":"10.2174\/1386207319666160610080716","volume":"19","author":"K Tiwari","year":"2016","unstructured":"Tiwari, K. et al. Cheminformatics Based Machine Learning Approaches for Assessing Glycolytic Pathway Antagonists of Mycobacterium tuberculosis. Comb Chem High Throughput Screen. 19, 667\u2013675, https:\/\/doi.org\/10.2174\/1386207319666160610080716 (2016).","journal-title":"Comb Chem High Throughput Screen."},{"key":"48192_CR44","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1128\/EC.00115-06","volume":"5","author":"A Rodaki","year":"2006","unstructured":"Rodaki, A., Young, T. & Brown, A. J. Effects of depleting the essential central metabolic enzyme fructose-1,6-bisphosphate aldolase on the growth and viability of Candida albicans: implications for antifungal drug target discovery. Eukaryot Cell. 5, 1371\u20131377, https:\/\/doi.org\/10.1128\/EC.00115-06 (2006).","journal-title":"Eukaryot Cell."},{"key":"48192_CR45","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1021\/acs.jcim.6b00763","volume":"57","author":"X Han","year":"2017","unstructured":"Han, X. et al. Structure-Based Rational Design of Novel Inhibitors Against Fructose-1,6-Bisphosphate Aldolase from Candida albicans. J Chem Inf Model. 57, 1426\u20131438, https:\/\/doi.org\/10.1021\/acs.jcim.6b00763 (2017).","journal-title":"J Chem Inf Model."},{"key":"48192_CR46","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0166-6851(99)00140-1","volume":"103","author":"S Walque","year":"1999","unstructured":"Walque, S., Opperdoes, F. R. & Michels, P. A. Cloning and characterization of Leishmania mexicana fructose-1,6-bisphosphate aldolase. Mol Biochem Parasitol. 103, 279\u2013283, https:\/\/doi.org\/10.1016\/S0166-6851(99)00140-1 (1999).","journal-title":"Mol Biochem Parasitol."},{"key":"48192_CR47","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1021\/jm050237b","volume":"49","author":"C Dax","year":"2006","unstructured":"Dax, C. et al. Selective irreversible inhibition of fructose 1,6-bisphosphate aldolase from Trypanosoma brucei. J Med Chem. 49, 1499\u20131502, https:\/\/doi.org\/10.1021\/jm050237b (2006).","journal-title":"J Med Chem."},{"key":"48192_CR48","doi-asserted-by":"publisher","first-page":"4388","DOI":"10.1021\/bi972233h","volume":"37","author":"H Kim","year":"1998","unstructured":"Kim, H., Certa, U., D\u00f6beli, H., Jakob, P. & Hol, W. G. Crystal structure of fructose-1,6-bisphosphate aldolase from the human malaria parasite Plasmodium falciparum. Biochemistry. 37, 4388\u20134396, https:\/\/doi.org\/10.1021\/bi972233h (1998).","journal-title":"Biochemistry."},{"key":"48192_CR49","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2174\/1568026618666180427150428","volume":"18","author":"LLG Ferreira","year":"2018","unstructured":"Ferreira, L. L. G., Ferreira, R. S., Palomino, D. L. & Andricopulo, A. D. Structure-Based Virtual Screening and Biochemical Evaluation for the Identification of Novel Trypanosoma brucei Aldolase Inhibitors. Curr Top Med Chem. 18, 397\u2013405, https:\/\/doi.org\/10.2174\/1568026618666180427150428 (2018).","journal-title":"Curr Top Med Chem."},{"key":"48192_CR50","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1016\/j.bmc.2015.02.059","volume":"23","author":"G Navarrete-V\u00e1zquez","year":"2015","unstructured":"Navarrete-V\u00e1zquez, G. et al. Synthesis of nitro(benzo)thiazole acetamides and in vitro antiprotozoal effect against amitochondriate parasites Giardia intestinalis and Trichomonas vaginalis. Bioorg Med Chem. 23, 2204\u20132210, https:\/\/doi.org\/10.1016\/j.bmc.2015.02.059 (2015).","journal-title":"Bioorg Med Chem."},{"key":"48192_CR51","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.2174\/138161212799436449","volume":"18","author":"RJ Bienstock","year":"2012","unstructured":"Bienstock, R. J. Computational drug design targeting protein-protein interactions. Curr Pharm Des. 18, 1240\u20131254, https:\/\/doi.org\/10.2174\/138161212799436449 (2012).","journal-title":"Curr Pharm Des."},{"key":"48192_CR52","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.bbapap.2010.10.008","volume":"1814","author":"A Peracchi","year":"2011","unstructured":"Peracchi, A. & Mozzarelli, A. Exploring and exploiting allostery: Models, evolution, and drug targeting. Biochim Biophys Acta. 1814, 922\u2013933, https:\/\/doi.org\/10.1016\/j.bbapap.2010.10.008 (2011).","journal-title":"Biochim Biophys Acta."},{"key":"48192_CR53","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1002\/prot.22393","volume":"76","author":"M Dechene","year":"2009","unstructured":"Dechene, M., Wink, G., Smith, M., Swartz, P. & Mattos, C. Multiple solvent crystal structures of ribonuclease A: an assessment of the method. Proteins. 76, 861\u2013881, https:\/\/doi.org\/10.1002\/prot.22393 (2009).","journal-title":"Proteins."},{"key":"48192_CR54","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1021\/jm061134b","volume":"50","author":"MR Landon","year":"2007","unstructured":"Landon, M. R., Lancia, D. R. Jr., Yu, J., Thiel, S. C. & Vajda, S. Identification of hot spots within druggable binding regions by computational solvent mapping of proteins. J Med Chem. 50, 1231\u20131240, https:\/\/doi.org\/10.1021\/jm061134b (2007).","journal-title":"J Med Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48192-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48192-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48192-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T12:30:35Z","timestamp":1671280235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48192-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,13]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["48192"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-48192-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,13]]},"assertion":[{"value":"19 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"11779"}}